News

ReNeuron recently applied to the FDA to request trials of a controversial treatment using the stem cells of fetuses to treat stroke patients. The worldwide market for Parkinson's

The study will examine the safety, tolerability and effectiveness of oral cladribine combined with a new formulation of Rebif in multiple sclerosis patients with active disease despite treatment

The marketing application is for the use of Thalidomide Pharmion in untreated multiple myeloma patients. Thalidomide Pharmion has been designated as an orphan medicinal product in the EU.

“Our preliminary human study demonstrates that OBE101, comprised of betahistine, offers a promising new approach to meet that need. Betahistine has a proven safety profile and has been

The British Medical Association has said that using the opium harvests could benefit the NHS and Afghanistan if the harvests are used to legally produce diamorphine, also known

Daily use of the antidepressant medications, known as selective serotonin reuptake inhibitors (SSRIs) by adults 50 years and older had a two-fold increased risk of incident clinical fragility

Davant will be examined in combination with 5-Fluorouracil (5-FU) to treat patients with advanced bile duct and gall bladder cancer. Phase I/II results showed that Davanat, when co-administered

The company intends to launch its product during the first quarter of 2007. Azithromycin for injection is indicated for the treatment in patients who require intravenous therapy for

Under the terms of the agreement, Medarex and Compugen plan to share discovery, development and commercialization responsibilities on antibody-based therapeutics resulting from this collaboration, and share revenues generated